Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.04−0.05 (-4.59%)
Close on Nov 17, 2026Market cap $9.37MP/E –Yield –
Lisata Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Lisata Therapeutics's price to book ratio was 1.3× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 0.2× to 3.0×, with a median of 0.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.3× | +0.4 |
| 2025 | Dec 31, 2025 | 0.9× | +0.2 |
| 2024 | Dec 31, 2024 | 0.7× | +0.3 |
| 2023 | Dec 29, 2023 | 0.4× | +0.1 |
| 2022 | Dec 30, 2022 | 0.3× | −0.2 |
| 2021 | Dec 31, 2021 | 0.5× | −0.2 |
| 2020 | Dec 31, 2020 | 0.7× | −0.3 |
| 2019 | Dec 31, 2019 | 1.0× | +0.2 |
| 2018 | Dec 31, 2018 | 0.9× | +0.2 |
| 2017 | Dec 29, 2017 | 0.6× | −1.5 |
| 2016 | Dec 30, 2016 | 2.2× | +1.1 |
| 2015 | Dec 31, 2015 | 1.1× | −1.0 |
| 2014 | Dec 31, 2014 | 2.1× | −1.9 |
| 2013 | Dec 31, 2013 | 4.0× | +2.1 |
| 2012 | Dec 31, 2012 | 1.9× | +1.2 |
| 2011 | Dec 30, 2011 | 0.7× | – |
See a number that looks wrong?